vdomain ig suppressor cell activation vista type transmembrane protein functions immune checkpoint encoded vista approximately belongs immunoglobulin superfamily one igv vista part family primarily expressed white blood cells transcription partially controlled evidence vista act cells inhibit cell effector function maintain peripheral vista produced high levels tumorinfiltrating lymphocytes myeloidderived suppressor cells regulatory cells blockade antibody results delayed tumor growth mouse models squamous cell monocytes hivinfected patients produce higher levels vista compared uninfected individuals increased vista levels correlated increase immune activation decrease ongoing cancer immunotherapy clinical trial monoclonal antibody targeting vista advanced preliminary results phase clinical trial show good safety tolerance anticancer activity patients advanced another ongoing clinical trial involves small molecule antagonizes programmed deathligands vista pathways patients advanced solid tumors